Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 181   

Articles published

BMY 56.77 -0.73 (-1.27%)
price chart
Bristol-Myers Squibb shares slip as kidney cancer drug trial falls short of goal
Bristol-Myers Squibb Co. BMY, +0.43% shares declined in the extended session Tuesday after the drugmaker said one of the endpoints of a kidney cancer drug study was not met.
3 Big Stock Charts for Tuesday: Bristol-Myers Squibb Co (BMY), United Parcel ...  Investorplace.com
BRIEF-Bristol-Myers Squibb announces topline results
BRIEF-Bristol-Myers Squibb announces topline results. 1 Min Read. Aug 15 (Reuters) - Bristol-myers Squibb Co: * Bristol-Myers Squibb announces topline results from checkmate -214, a phase 3 study of opdivo in combination with yervoy in intermediate and ...
Hardesty Capital Management Corp Buys Bristol-Myers Squibb Company, Helmerich ...
Hardesty Capital Management Corp added to the holdings in Bristol-Myers Squibb Company by 23.52%. The purchase prices were between $51.66 and $57.33, with an estimated average price of $54.38.
Earnings Reaction History: Bristol Myers Squibb Co, 45.5% Follow-Through ...
Bristol Myers Squibb Co ( BMY ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement ...
Bridges Investment Management Inc Buys Bristol-Myers Squibb Company, Bristol ...
Bridges Investment Management Inc initiated holdings in Salesforce.com Inc. The purchase prices were between $49.69 and $52.94, with an estimated average price of $51.48.
Adams Express Co Buys Bristol-Myers Squibb Company, Bristol-Myers Squibb ...  GuruFocus.com
What's in the Offing for Bristol-Myers (BMY) in Q2 Earnings?  Yahoo Finance
Bristol-Myers Squibb plans 58 layoffs as drug patents expire
LAWRENCE -- Drugmaker Bristol-Myers Squibb Co. plans to lay off 58 workers as it prepares to lose its patent exclusivity on the HIV drugs Sustiva and Reyataz at the end of the year.
Taking a Look at the Data Behind Bristol-Myers Squibb Company (BMY)  StockNewsJournal
V Wealth Management LLC Takes Position in Bristol-Myers Squibb Co (BMY)  Newburgh Gazette
Trustco Bank Corp NY Buys Medtronic PLC, Bristol-Myers Squibb Company ...
Trustco Bank Corp N Y initiated holdings in Medtronic PLC. The purchase prices were between $80.01 and $89.3, with an estimated average price of $84.19.
Bristol-Myers Squibb to Acquire IFM Therapeutics in $300M Upfront Deal
Bristol-Myers Squibb Company and IFM Therapeutics (IFM) announced that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the outstanding capital stock of IFM Therapeutics, a venture-backed biotech ...
Bristol-Myers - Adding To The Pipeline With IFM  Seeking Alpha
Bristol-Myers Squibb (BMY) Could Be Worth $59-$75 In Takeout W/O CM-227 ...  StreetInsider.com
Bristol-Myers Squibb Stock Falls as Kidney Cancer Drug Fails
Bristol-Myers Squibb Co. (BMY) shares were down 0.62% to $57.52 in early morning trading Wednesday after the company announced that its kidney cancer drug trial failed to show efficacy during trials.
Bristol-Myers Squibb Combination Treatment Not At The End Of The Crossroad  Seeking Alpha
Price Alert: Bristol-Myers Squibb Company (NYSE:BMY) Stock Nears Resistance ...  CML News
Bristol-Myers Squibb to Acquire IFM Therapeutics to Strengthen Oncology ...
NEW YORK & BOSTON--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and IFM Therapeutics (IFM) announced today that the companies have signed a definitive agreement under which Bristol-Myers Squibb will acquire all of the ...
Bristol-Myers pays $300 million for Cambridge biotech  The Boston Globe
Bristol-Myers Squibb: The Aftermath  Law360 (subscription)